US Stock MarketDetailed Quotes
FBRX Forte Biosciences
- 11.450
- -2.100-15.50%
Trading Nov 21 11:10 ET
16.74MMarket Cap-699P/E (TTM)
12.400High10.110Low464.20KVolume12.250Open13.550Pre Close5.19MTurnover50.52%Turnover RatioLossP/E (Static)1.46MShares21.25052wk High1.79P/B10.52MFloat Cap4.11052wk Low--Dividend TTM918.91KShs Float6732.375Historical High--Div YieldTTM16.90%Amplitude4.110Historical Low11.178Avg Price1Lot Size
Forte Biosciences Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 10.21%-8.13M | -8.42%-5.94M | -28.11%-6.67M | -250.71%-28.71M | -210.02%-8.97M | -366.91%-9.06M | -297.60%-5.48M | -163.49%-5.2M | 50.92%-8.19M | 19.24%-2.89M |
| Net income from continuing operations | 15.70%-8.39M | -40.64%-12.51M | -9.88%-7.42M | -126.79%-31.48M | -20.40%-5.87M | -192.79%-9.96M | -193.11%-8.9M | -163.07%-6.75M | 36.07%-13.88M | -45.97%-4.88M |
| Depreciation and amortization | 233.33%10K | --10K | --9K | --9K | --6K | --3K | --0 | --0 | --0 | --0 |
| Other non cash items | ---- | ---- | ---- | ---131K | ---- | ---- | ---- | ---- | ---- | ---- |
| Change In working capital | -329.58%-551K | 122.96%5.77M | -108.18%-55K | -123.35%-392K | -446.17%-3.89M | -56.68%240K | 457.54%2.59M | 245.14%672K | 133.19%1.68M | 176.00%1.12M |
| -Change in prepaid assets | 98.50%-13K | -122.08%-17K | 206.59%279K | -429.07%-849K | -182.42%-150K | -335.68%-867K | -67.37%77K | 133.33%91K | -78.87%258K | -63.82%182K |
| -Change in payables and accrued expense | -148.60%-538K | 130.48%5.79M | -157.49%-334K | -67.84%457K | -497.13%-3.74M | 47.01%1.11M | 1,000.88%2.51M | 215.74%581K | 383.63%1.42M | 147.53%942K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 10.21%-8.13M | -8.42%-5.94M | -28.11%-6.67M | -250.71%-28.71M | -210.02%-8.97M | -366.91%-9.06M | -297.60%-5.48M | -163.49%-5.2M | 50.92%-8.19M | 19.24%-2.89M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | -6K | 47K | -16K | 10.03M | -9.97M | 0 | 0 | 0 |
| Net PPE purchase and sale | --0 | --0 | ---6K | ---88K | ---17K | ---71K | --0 | --0 | --0 | --0 |
| Net investment purchase and sale | --0 | ---- | ---- | --135K | --1K | --10.1M | ---- | ---- | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | ---6K | --47K | ---16K | --10.03M | ---9.97M | --0 | --0 | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -100.01%-2K | 58.33%-10K | -233.33%-8K | 240.89%24.68M | -36.36%-75K | 233.02%24.78M | 78.18%-24K | 117.65%6K | 16,556.82%7.24M | -41.03%-55K |
| Net common stock issuance | ---- | ---- | ---- | 242.07%24.73M | -16.36%-64K | ---- | ---- | ---- | --7.23M | ---55K |
| Proceeds from stock option exercised by employees | -33.33%6K | --0 | 33.33%8K | 33.33%16K | --1K | --9K | --0 | -50.00%6K | -80.65%12K | --0 |
| Net other financing activities | 70.83%-7K | ---10K | ---16K | ---60K | ---12K | ---24K | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -100.01%-2K | 58.33%-10K | -233.33%-8K | 240.89%24.68M | -36.36%-75K | 233.02%24.78M | 78.18%-24K | 117.65%6K | 16,556.82%7.24M | -41.03%-55K |
| Net cash flow | ||||||||||
| Beginning cash position | 19.86%24.5M | -15.20%30.44M | -9.67%37.13M | -2.25%41.1M | 4.85%46.19M | -46.98%20.44M | -10.32%35.9M | -2.25%41.1M | -28.45%42.04M | -3.54%44.05M |
| Current changes in cash | -131.60%-8.14M | 61.55%-5.95M | -28.53%-6.68M | -321.08%-3.98M | -207.33%-9.06M | 368.13%25.75M | -939.95%-15.46M | -158.74%-5.2M | 94.35%-944K | 18.59%-2.95M |
| End cash Position | -64.57%16.36M | 19.86%24.5M | -15.20%30.44M | -9.67%37.13M | -9.67%37.13M | 4.85%46.19M | -46.98%20.44M | -10.32%35.9M | -2.25%41.1M | -2.25%41.1M |
| Free cash flow | 10.91%-8.13M | -8.42%-5.94M | -28.23%-6.67M | -251.79%-28.79M | -210.61%-8.99M | -370.57%-9.13M | -297.60%-5.48M | -163.49%-5.2M | 50.92%-8.19M | 19.24%-2.89M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
